Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups

Schenkel, Karl; Radun, Doris; Bremer, Viviane; Bocter, Nikolaus; Hamouda, Osamah
January 2008
BMC Public Health;2008, Vol. 8 Issue 1, p132
Academic Journal
Background: In Germany, vaccination against hepatitis B is recommended for infants, children and adolescents since 1995 and for specific target groups since 1982. Little is known about knowledge about viral hepatitis and attitudes toward hepatitis B vaccination-factors likely to influence vaccine uptake. Methods: In order to estimate vaccination coverage in adult target groups and in the overall adult population and to assess knowledge and attitudes, we conducted a nationwide cross-sectional telephone survey among 412 persons in November 2004. We defined participants as being vaccinated if they reported at least one previous vaccination against hepatitis B. Results: Vaccination coverage (vc) standardised for age, sex and residence was 29.6% in the general population and 58.2% in target groups for hepatitis B vaccination. Particular gaps in vaccine coverage were detected among health care workers (vc: 69.5%) and chronically ill persons (vc: 22.0%). Knowledge on risk factors and transmission was far below expectations, whereas the acceptance of vaccination in the majority of the population (79.0%) was good. Conclusion: We conclude that educational measures could lead to a higher vaccination uptake in adult target groups.


Related Articles

  • Ocular Vaccinia: A Consequence of Unrecognized Contact Transmission. Montgomery, Jay R.; Carroll, Robert B.; McCollum, Andrea M. // Military Medicine;Jun2011, Vol. 176 Issue 6, p699 

    A patient developed severe ocular vaccinia via autoinoculation after acquiring unrecognized contact-transmitted vaccinia from wrestling with vaccinated members of his unit. This case highlights both the need to reinforce infection-control measures among vaccinees and the need for providers to be...

  • Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. Beutels, P.; Edmunds, W.J.; Antoñanzas, F.; de Wit, G.A.; Evans, D.; Feilden, R.; Fendrick, A.M.; Ginsberg, G.M.; Glick, H.A.; Mast, E.; Péchevis, M.; van Doorslaer, E.K.A.; van Hout, B.A.; Beutels, Philippe; Edmunds, W John; Antoñanzas, Fernando; De Wit, G Ardine; Evans, David; Feilden, Rachel; Fendrick, A Mark // PharmacoEconomics;2002, Vol. 20 Issue 1, p1 

    The methods that have been used to estimate the clinical and economic impact of vaccination programmes are not always uniform, which makes it difficult to compare results between economic analyses. Furthermore, the relative efficiency of vaccination programmes can be sensitive to some of the...

  • The Epidemiology of Viral Hepatitis in Children in South Texas: Increased Prevalence of Hepatitis A along the Texas-Mexico Border. Leach, Charles T.; Koo, Felix C.; Hilsenbeck, Susan G.; Jenson, Hal B. // Journal of Infectious Diseases;8/1/99, Vol. 180 Issue 2 

    Examines the epidemiology of viral hepatitis in children in South Texas. Risk factors for hepatitis A infection; Determination on the sources of hepatitis A infection; Effectiveness of vaccines in reducing acute illness and complications associated with hepatitis A.

  • Epaxal.  // Royal Society of Medicine: Medicines;2002, p229 

    The article presents information on Epaxal, a proprietary, prescription-only preparation of hepatitis A vaccine. It can be used to protect people at risk from infection with hepatitis A, and is available in a form for injection.

  • Inmunogenicidad de una vacuna recombinante anti-HBs en trabajadores de la salud, del Instituto de Medicina Legal de Colombia. Siachoque, Heber; Ibáñez, Milcíades // Colombia Medica;oct-dec2007, Vol. 38 Issue 4, p375 

    Objective: To evaluate the immunogenicity of Hepavax-Gene recombinant hepatitis B vaccine in INML workers since the last administered doses. Methods: Cross-sectional study on 603 health workers with at least three administered recombinant vaccine doses. Antibody levels (anti-HBs) were measured...

  • Havrix Monodose.  // Royal Society of Medicine: Medicines;2002, p278 

    The article presents information on Havrix Monodose, a proprietary, prescription-only preparation of the hepatitis A vaccine. It can be used to protect people at risk from infection with hepatitis A, and is available in a form for injection.

  • Immunoprophylaxis of Viral Hepatitis: A Practical Guide. Schiff, E. // American Journal of Gastroenterology;Apr1987, Vol. 82 Issue 4, p287 

    Presents a guide for practicing gastroenterologists on indications and recommendations for immunoprophylaxis of viral hepatitis. Background on different types of viruses that may cause hepatitis; Information on passive and active vaccines for hepatitis; Factors to consider in relation to...

  • Hepatitis B Control in China: Knowledge and Practices among Village Doctors. Clayton, Serena; Honglian Yang; Jihui Guan; Zhongsu Lin; Rui Wang // American Journal of Public Health;Dec1993, Vol. 83 Issue 12, p1685 

    Objectives. To guide development of a hepatitis B control program in China, we investigated village doctors' sterilization practices, injection use, vaccination levels, and knowledge and counseling skills. Methods. The head doctor from each village health station in a rural county (n = 260)...

  • Vitamin D Boosts Efficacy Of Hepatitis B Shot in Men.  // Nutrition Health Review: The Consumer's Medical Journal;2013, Issue 109, p18 

    The article reports that according to a report vitamin D boosts the efficacy of hepatitis B shot in men.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics